华博生物医药技术（上海）有限公司基本信息

Huabo Biopharm Co., Ltd., a wholly owned subsidiary of Huahai Pharmaceutical, is a start-up biotech company dedicated to discovery, development, and commercializing of breakthrough therapies with the potential to deliver meaningful clinical benefit to tumor patients. The management team is consisted of several over-sea scholars and all have profound knowledge and comprehensive experiences both in industrial as well as in academic area. We are committed to excellence and strike to make a difference every day. We are currently advancing a pipeline of promising preclinical candidates and have robust research capabilities fuelling our long-term growth.